KARACHI: Ghani Chemical Industries Limited (GCIL) reported a strong financial performance for the nine months ended March 31, 2026, posting a significant increase in profitability driven by higher sales and improved operating performance. The company’s board of directors also announced that no cash dividend, bonus shares, or right shares would be issued for the period.
According to the company’s financial results, net sales rose to Rs5.99 billion during the nine-month period, compared with Rs5.33 billion in the corresponding period last year, reflecting steady growth in demand for the company’s products. Gross profit climbed to Rs3.25 billion, up from Rs2.50 billion a year earlier, highlighting improved operational efficiency and stronger margins.
Profit from operations increased to Rs2.64 billion, compared with Rs2.28 billion in the same period last year. Despite higher finance costs of Rs425.69 million, the company recorded a profit after tax of Rs1.93 billion, representing an increase of nearly 58% from Rs1.22 billion reported in the corresponding period of the previous year.
Earnings per share (EPS) improved to Rs3.38, compared with Rs2.43 in the same period last year, reflecting the company’s enhanced profitability and value creation for shareholders.
On the balance sheet, total assets expanded to approximately Rs19.38 billion as of March 31, 2026, from Rs16.25 billion at the end of June 2025. Total equity also strengthened, increasing to Rs10.72 billion, supported by higher retained earnings generated during the period.
The company generated positive cash flows from financing activities during the period, although operating cash flows remained under pressure due to higher working capital requirements, particularly increases in trade receivables and loans and advances. Capital expenditure also continued as the company invested in expanding and maintaining its production capacity.
The Board of Directors, in its meeting held on April 28, 2026, decided not to recommend any interim cash dividend, bonus shares, or right shares for the nine-month period ended March 31, 2026.
The latest results underscore Ghani Chemical Industries’ continued earnings momentum, supported by rising revenues, stronger gross margins, and sustained growth in its core industrial and medical gases business, positioning the company for continued expansion despite a higher financing cost environment.
